RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Japan's health ministry has approved five types of coronavirus vaccines for use in this season's campaign that starts on October 1.

Aurora Biosynthetics, a pioneering RNA therapeutics manufacturer company, announced its official launch, ushering in a new ...

Novo Nordisk's deal with Korro is worth a total of $530 million in research and development (R&D) funding, milestone payments, royalties, and up-front payments to get the ball rolling. That makes the ...

Cartesian Therapeutics has a strong cash position after a $130 million equity raise, extending its runway to support upcoming ...

Arcturus Therapeutics Holdings Inc. ARCT is engaged in developing messenger RNA (mRNA) medicines and vaccines based on its ...

Long known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system — even between ...

Results from the first-in-human trial of a new mRNA-based cancer vaccine are promising, as are early results from two other ...

An accidental discovery turned into an unexpected success when a team of interdisciplinary BU researchers created a new and ...

The global pipette tips market is on the cusp of significant expansion, with forecasts indicating an impressive Compound ...

British drugmaker GSK on Thursday announced positive results from its mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, saying it would now ...